| JXSL1900066 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Import Drug Application | 2019-08-01 | 美信美达医药信息咨询（北京）有限责任公司 | Meixin Meida Medical Information Consulting (Beijing) Co Ltd | In Review | 2019-07-31 | view |
| JXSS2000017 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2020-05-27 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-26 | view |
| JYSB2000654 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-12-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2021-01-06 | view |
| JXSS1900013 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2019-03-27 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-01-22 | view |
| JYSB2000426 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-09-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-11 | view |
| JYSB2000332 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-06-30 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-07-01 | view |
| JXSS1900012 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2019-03-27 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-01-22 | view |
| JYSB2000194 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-05-25 | view |
| JYSB2000331 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-06-30 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-07-01 | view |
| JYSB2000193 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-05-25 | view |
| JYSB2000425 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-09-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-11 | view |
| JXSS2000016 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2020-05-27 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-26 | view |
| JYSB2000653 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-12-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2021-01-06 | view |
| JTS1900038 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Disposable Import Drug Application | 2019-08-03 | 瑞士罗氏制药有限公司F. Hoffman-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2019-09-04 | view |
| JTS1900039 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Disposable Import Drug Application | 2019-08-03 | 瑞士罗氏制药有限公司 F. Hoffman-La Roche Ltd. | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2019-09-04 | view |
| JXSL0900083 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Import Drug Application | 2009-12-04 | 深圳万乐药业有限公司 | Shenzhen Main Luck Pharmaceuticals INC | Certificate Issued | 2011-03-07 | view |
| CXSL1400013 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(2) | New Drug Application | 2014-04-30 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2016-09-26 | view |
| CXSL1400077 | 注射用重组抗人表皮生长因子受体2(HER2)单抗(曲妥珠单抗) | trastuzumab | Lyophilized | Biological Products(2) | New Drug Application | 2014-09-12 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-07-21 | view |
| JXSL1900088 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Import Drug Application | 2019-09-11 | 上海艾迈医疗科技有限公司 | 7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited | In Review | 2019-09-10 | view |
| JYSB0600001 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2006-01-12 | 上海罗氏制药有限公司北京办事处 | Shanghai Roche Pharmaceuticals Ltd Beijing | Certificate Completed-Pending Issued | 2006-05-30 | view |
